Literature DB >> 9336147

Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate.

S Nag1, S Vivekanandam, R Martínez-Monge.   

Abstract

PURPOSE: It has been reported that permanently implanted iodine-125 seeds can embolize to the lungs. There is little data on the embolization of palladium-103 seeds. The purpose of this study is to collect and evaluate data on the embolization of Pd-103 seeds. METHODS AND MATERIALS: The records of 112 patients implanted with Pd-103 for carcinoma of the prostate were reviewed to systemically study the incidence and dynamics of pulmonary embolism of Pd-103 seeds. Five patients had no postoperative chest radiograph and were thus excluded, leaving 107 patients for review.
RESULTS: Chest radiographs of 19 of the 107 patients showed embolized seeds in the lungs (18%). Two patients had three seeds each, nine patients had two seeds each; and in the remaining eight patients, a single seed migrated to the lungs. The seeds migrated mainly (84%) to the lower lobes. None of the eight patients who had their first postoperative chest radiograph on the day of the implant showed any embolized seeds. The embolized seed appeared only on subsequent chest radiographs taken 27 to 40 days later. Ten of the other 11 patients who had their first radiograph 1 to 97 days after brachytherapy had embolized seeds on their first chest radiograph. In the other patient, the embolized seed appeared only on a subsequent chest radiograph taken after 127 days. There were no clinical pulmonary or cardiac effects evident on routine follow-up of these patients with pulmonary embolized seeds.
CONCLUSION: Embolization of Pd-103 seeds to the lungs after implantation for carcinoma of the prostate is an unusual event. In this study only 0.3% of the seeds implanted migrated to the lungs. Although it was previously thought that pulmonary seed migration mainly occurred on the day of brachytherapy, our experience shows that seeds usually migrated to the lungs after the day of the implant. There were no clinical pulmonary or cardiac effects attributable to embolized seeds in the lungs on routine follow-up.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9336147     DOI: 10.1016/s0360-3016(97)00342-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.

Authors:  Katsumi Hirose; Masahiko Aoki; Mariko Sato; Hiroyoshi Akimoto; Yasuhiro Hashimoto; Atsushi Imai; Noritaka Kamimura; Hideo Kawaguchi; Yoshiomi Hatayama; Ichitaro Fujioka; Mitsuki Tanaka; Chikara Ohyama; Yoshihiro Takai
Journal:  Jpn J Radiol       Date:  2016-09-08       Impact factor: 2.374

2.  Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors.

Authors:  Katsuhito Miyazawa; Munetaka Matoba; Hiroshi Minato; Nobuyo Morita; Ippei Chikazawa; Kiyotaka Ota; Kosuke Tokunaga; Hisao Tonami; Takayuki Nojima; Koji Suzuki
Journal:  Jpn J Radiol       Date:  2012-07-14       Impact factor: 2.374

3.  [Seed migration to the vertebral venous plexus after prostate brachytherapy].

Authors:  W Wagner; N Willich; A Radmard; A Christ; P W Fleig; M G Krukemeyer
Journal:  Urologe A       Date:  2010-11       Impact factor: 0.639

4.  Prostate brachytherapy: HDR or seed implant.

Authors:  K R Das
Journal:  J Med Phys       Date:  2006-10

5.  Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds.

Authors:  Akitomo Sugawara; Jun Nakashima; Etsuo Kunieda; Hirohiko Nagata; Ryuichi Mizuno; Satoshi Seki; Yutaka Shiraishi; Ryuichi Kouta; Mototsugu Oya; Naoyuki Shigematsu
Journal:  Radiat Oncol       Date:  2011-10-05       Impact factor: 3.481

6.  Treatment planning consideration for prostate implants with the new linear RadioCoil 103Pd brachytherapy source.

Authors:  Ali S Meigooni; Shahid B Awan; Venkata Rachabatthula; Rafiq A Koona
Journal:  J Appl Clin Med Phys       Date:  2005-08-12       Impact factor: 2.102

7.  Prostate brachytherapy seed migration to the heart seen on cardiovascular computed tomographic angiography.

Authors:  Shilpa Sachdeva; Nneka S Udechukwu; Hossam Elbelasi; Kevin P Landwehr; William H St Clair; Michael A Winkler
Journal:  Radiol Case Rep       Date:  2016-11-22

8.  Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.

Authors:  Masahiro Nakano; Atsunori Yorozu; Shiro Saito; Akitomo Sugawara; Shinichiroh Maruo; Shinsuke Kojima; Takashi Kikuchi; Masanori Fukushima; Takushi Dokiya; Hidetoshi Yamanaka
Journal:  Radiat Oncol       Date:  2015-11-14       Impact factor: 3.481

9.  Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.

Authors:  Katsumi Hirose; Masahiko Aoki; Mariko Sato; Hiroyoshi Akimoto; Yasuhiro Hashimoto; Atsushi Imai; Noritaka Kamimura; Hideo Kawaguchi; Yoshiomi Hatayama; Ichitaro Fujioka; Mitsuki Tanaka; Chikara Ohyama; Yoshihiro Takai
Journal:  Radiat Oncol       Date:  2017-12-01       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.